Independent assessment of a point of care HCV RNA test by laboratory analytical testing and a prospective field study in the U.S
Open Access
- 22 July 2025
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (7) , e0324088
Abstract
Improvements in HCV testing, including Point of Care (POC) HCV RNA tests, are necessary to eliminate HCV. With this goal in mind, we established methods to collect capillary whole blood (CWB) via fingerstick, ensured its stability in a microtainer, and determined limit of detection (LoD) for various HCV genotypes. Next, we conducted a prospective study where CWB samples were collected from a cohort of 109 adult subjects at a safety-net hospital and tested for HCV RNA using the Xpert® HCV test on the GeneXpert® Xpress system and the cobas® HCV platform. We consistently obtained 250 μl CWB which was stable for up to 5 hours in the microtainer. Laboratory LoD studies demonstrated that the Xpert® HCV test could detect most HCV genotypes to <100 IU/ml in CWB. In the prospective clinical study, 89 subjects (82%) with valid Xpert® and cobas® HCV comparator results were analyzed. Using Xpert®, 16 out of 89 (18%) subjects had detectable HCV RNA and 73 (82%) had undetectable HCV RNA. Using cobas, 17 out of 89 (19%) participants had detectable HCV RNA, and 72 (81%) were undetectable. One sample was detectable on cobas but not Xpert®, yielding a sensitivity of 94% and specificity of 100%. This study demonstrates the feasibility of HCV RNA testing at POC using CWB obtained by fingerstick and provides preliminary data on the accuracy of the Xpert® HCV test performed by untrained operators in a CLIA-waived setting.Keywords
All Related Versions
Funding Information
- NIBIB (75N92022D00015/75N92022F00003; 75N92022D00013/75N92022F00004, 75N92022D00014/75N92023F00001)
This publication has 19 references indexed in Scilit:
- A ‘one-stop-shop’ point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: The PIVOT studyJournal of Hepatology, 2023
- A National Hepatitis C Elimination Program in the United StatesJAMA, 2023
- Impact of hepatitis C virus point-of-care RNA viral load testing compared with laboratory-based testing on uptake of RNA testing and treatment, and turnaround times: a systematic review and meta-analysisThe Lancet Gastroenterology & Hepatology, 2023
- Diagnostic Accuracy of Assays Using Point-of-Care Testing or Dried Blood Spot Samples for the Determination of Hepatitis C Virus RNA: A Systematic ReviewThe Journal of Infectious Diseases, 2022
- Time matters: Point of care screening and streamlined linkage to care dramatically improves hepatitis C treatment uptake in prisoners in EnglandInternational Journal of Drug Policy, 2020
- Deriving the optimal limit of detection for an HCV point-of-care test for viraemic infection: Analysis of a global datasetJournal of Hepatology, 2019
- Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in AustraliaInternational Journal of Drug Policy, 2018
- Evaluation of the Xpert HCV Viral Load Finger-Stick Point-of-Care AssayThe Journal of Infectious Diseases, 2018
- Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysisThe Lancet Infectious Diseases, 2016
- Strategies for Hepatitis C Testing and Linkage to Care for Vulnerable Populations: Point-of-Care and Standard HCV Testing in a Mobile Medical ClinicJournal of Community Health, 2014